Cofact
WikiDoc Resources for Cofact |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cofact at Clinical Trials.gov Clinical Trials on Cofact at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cofact
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Cofact Risk calculators and risk factors for Cofact
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Cofact is a combination of blood clotting factors II, VII, IX and X. It consists of a protein fraction prepared from fresh-frozen human blood plasma. It is used in patients receiving oral anticoagulation therapy for the treatment and prevention of thrombosis when bleeding occurs (e.g. in the brain) requiring rapid action to accelerate coagulation. It is also used when such a patient must undergo an emergency operation treatment. Other indications include a deficiency of one of the included clotting factors, either congenital or due to liver disease. It is available as a powder and solvent for solution for injection.